Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/12/24
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 05/01/18
End: 01/01/19
Due: 01/01/20
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies | NCT06787482 | Ace Cells Lab Limited | user2@example.com | None | 2024-11-12 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |
| Revitalization of Damaged Skin Due to Chronic Skin Diseases | NCT03485560 | Ace Cells Lab Limited | user2@example.com | None | 2018-05-01 | 2019-01-01 | 2020-01-01 | - | - | 2025-07-14 |